ICD-10-CM 2026 · Effective October 1, 2025

ICD-10 D63.0

Billable / Specific

Anemia in neoplastic disease

D63
Block
0
Synonyms
181
LCDs
10
Payer Policies
0
Linked CPTs

About ICD-10-CM D63.0

ICD-10-CM code D63.0 represents Anemia in neoplastic disease. This is a billable/specific code in the Blood and Blood-forming Organs chapter (block D63). The 2026 edition of ICD-10-CM D63.0 became effective on October 1, 2025.

Type 1 Excludes

Pure excludes, these codes can never be coded together with D63.0. The conditions are mutually exclusive (e.g., congenital vs acquired forms).

  • aplastic anemia due to antineoplastic chemotherapy (D61.1)

Type 2 Excludes

Not included here, the excluded code is not part of D63.0, but a patient may have both conditions at the same time. Both codes may be coded together when applicable.

  • anemia due to antineoplastic chemotherapy (D64.81)

Coding Notes

Code First

  • neoplasm (C00-D49)

Medicare LCD Coverage for D63.0

Local Coverage Determinations (LCDs) from CMS MACs that list D63.0 as a covered diagnosis.

181 LCDs

Showing top 10 of 181 total . Click a CPT for full coverage scope.

CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 0198U →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 81109 →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 0197U →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 0183U →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 81107 →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 0186U →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 81106 →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 0184U →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 0221U →
CMS LCD: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Article ID: 57155, Effective: 2024-10-01 00:00:00, 115 covered, 0 non-covered
CPT 0200U →

Commercial Payer Coverage

Coverage policies from major commercial payers referencing D63.0.

10 policies

1 Cigna

Flow Cytometry - (0538)
Policy ID: MM_0538

5 Medicare

Billing and Coding: Lab: Flow Cytometry
Policy ID: ART-55717
Billing and Coding: Flow Cytometry
Policy ID: ART-56464
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Policy ID: ART-57110
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Policy ID: ART-57124
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
Policy ID: ART-57155

2 Aetna

Erythropoiesis Stimulating Agents
Policy ID: CPB-0195
Intravenous Iron Therapy
Policy ID: CPB-0575

CPT Codes Commonly Billed with D63.0

Procedures frequently paired with this diagnosis based on PayerReady's Dx↔Px linkage data.

No procedure linkages on file for D63.0

We don't have CPT pairings indexed for this specific code yet. Use the CPT search above to find common procedures, or check your payer's published medical policy for code-specific guidance.

Convert D63.0 to ICD-9-CM

Per CMS General Equivalence Mappings (GEMs), useful for legacy data review and historical claim analysis.

ICD-10ICD-9Mapping Flags
D63.0 28522 00000

Flags format (5 digits): Approximate · No Map · Combination · Scenario · Choice List. Source: CMS 2017 GEMs (final version).

ICD-10 D63.0, Billing FAQ

Is ICD-10 code D63.0 billable? +

Yes, D63.0 is a billable ICD-10-CM code that can appear as a primary or secondary diagnosis on claims.

What codes are Type 1 Excludes for D63.0? +

Type 1 Excludes (never code together with D63.0): aplastic anemia due to antineoplastic chemotherapy (D61.1)

What codes are Type 2 Excludes for D63.0? +

Type 2 Excludes (may be coded together when both conditions exist): anemia due to antineoplastic chemotherapy (D64.81)

What ICD-9 codes does D63.0 map to? +

Per CMS GEMs, D63.0 maps to ICD-9 codes: 28522. Useful for legacy data review and historical claim analysis.

Get the full PayerReady toolkit

Free access to CPT/ICD-10 lookup, denial appeals, fee comparator, and claim auditing with credentialing enrollment.

Start free →

Run this code through our claim audit tool

Check NCCI bundling, MUE limits, and modifier logic before submission.

Try the auditor →

Did this page help?

Quick signal so we know what to improve.

Thanks!

If you want a code reference page that doesn't exist yet, email coding@payerready.com.

Sorry to hear that.

Tell us what's missing or wrong: coding@payerready.com. We respond within 5 business days.

Reviewed by the PayerReady Medical Coding Team

Verified against the CMS 2026 code set on May 31, 2026.

Powered by 11K CPT · 98K ICD-10 · 860K MPFS rates · 4.5M NCCI edits · 9.5M NPIs. Our data methodology · About our coding team

Faster Approvals

Ready to Cut Your Enrollment Timeline in Half?

Join providers in all 50 states who handed off credentialing to a dedicated specialist. Create your free account in minutes and start enrolling the same day.

All 50 States Covered
No Long-Term Contracts
HIPAA HIPAA Compliant Platform
Dedicated Specialist Included